What You Should Know
- Counsel Health officially launches its dedicated weight management program, integrating obesity pharmacotherapy with comprehensive primary care.
- As part of the commercial rollout, Counsel Health is collaborating with LillyDirect, the direct-to-consumer digital pharmacy initiative developed by Eli Lilly and Company.
- The program responds to sharp shifts in national prescribing patterns, with the percentage of American adults taking GLP-1 medications for weight loss climbing to 11% in 2026, up from 3% in 2024.
Whole-Person Primary Care vs. Isolated Prescribing
Founded by physician and former Notable Health Chief Medical Officer Dr. Muthu Alagappan, Counsel Health differentiates its model by rejecting the notion that obesity can be treated as an isolated cosmetic concern. Because obesity frequently coexists with complex metabolic and mechanical comorbidities, Counsel wraps weight management inside a full-stack, longitudinal primary care practice:
- Comprehensive Chronic Condition Management: Rather than siloing weight loss, Counsel’s board-certified physicians manage obesity in the context of associated conditions, including essential hypertension, type 2 diabetes, hyperlipidemia, obstructive sleep apnea, and musculoskeletal joint pain.
- Proactive Medical AI & Rapid Physician Escalation: Operating across the 44 states where Counsel is licensed, the platform deploys clinically supervised medical AI that proactively checks in on patient progress, monitors titration tolerance, and flags adverse gastrointestinal side effects. Members can query the AI at any time at zero cost or connect with an in-house physician on demand—typically within minutes.
- Expanded Pharmacotherapy Formulary: Following digital clinical intake and comprehensive physician evaluation, Counsel clinicians prescribe guideline-directed therapies when clinically indicated, spanning subcutaneous injectables like Zepbound® (tirzepatide) and Wegovy® (semaglutide), as well as emerging oral small-molecule options including Foundayo™ (orforglipron).
Dr. Muthu Alagappan emphasized the care philosophy: “GLP-1s are powerful medications, but a prescription alone is not a care model. Patients managing obesity benefit from ongoing access to physicians who understand their health journey and take a holistic approach to primary care. We built Counsel to democratize this experience for millions of people.”
Disrupting DTC Economics: Cash-Pay Transparency and Direct LillyDirect Integration
A core barrier to sustained cardiometabolic therapy is the high out-of-pocket cost of digital clinic memberships, which often run between $99 and $149 per month on top of prescription pharmacy costs. Counsel leverages its AI-native triage and intake platform to reduce clinician overhead, offering low-cost cash pricing designed to drive multi-year retention.
Counsel Signature Annual Membership offers unlimited on-demand access to Counsel physicians for $300 per year (equivalent to $25 per month), covering both weight management and broader primary and urgent care needs. For patients seeking episodic oversight, the platform provides a $29 per-visit option with no ongoing membership commitment.
Consumers accessing care through the LillyDirect digital health portal can select Counsel Health alongside other virtual providers. The integration routes patients into Counsel’s chat-first clinical engine, connecting them with a physician in an average of fifteen minutes to coordinate clinical evaluation, home delivery, or local pharmacy pickup.
